Investing-News.Com
Information for Investors

QUIGLEY CORP THE, (QGLY) Stock Research - Investing-News.Com
 

 Home   Market News   Analysis   Commentary   Education   Tools   Weekly Report 

Internet Search   Stock Search
   

 

QUIGLEY CORP THE, (QGLY) Stock Research Free Stock Rating

 
Company Profile
 
The Quigley Corporation engages in the development, manufacture, and distribution of homeopathic and health products. It operates in four segments: Cold Remedy, Health and Wellness, Contract Manufacturing, and Ethical Pharmaceutical. The Cold Remedy segment offers Cold-Eeze, a zinc gluconate glycine formulation. Cold-Eeze is an over-the-counter consumer product used to reduce the duration and severity of the common cold; and is sold in lozenge, sugar-free tablet, and gum forms. The Health and Wellness segment specializes in the development and distribution of proprietary health and wellness products, including herbal vitamins and dietary supplements for the human condition, primarily within the United States. The Contract Manufacturing segment produces lozenge product. It warehouses and ships the company's Cold-Eeze products. This segment also produces a variety of hard and organic candy for sale to third party customers, as well as engages in contract manufacturing activities for nonrelated entities. The Ethical Pharmaceutical segment involves in the research and development of naturally derived prescription drugs, cosmeceuticals, and dietary supplements. The Quigley was organized in 1989 by Guy J. Quigley and Charles A. Phillips. The company is headquartered in Doylestown, Pennsylvania.

QUIGLEY CORP THE Related

Quigley Developer and marketer of diversified health products, including the Cold-Eeze family of zinc gluconate glycine lozenges, gums, and tablets.
QGLY - Stock Quote for Quigley Corp - MSN Money QGLY - Get a stock quote for Quigley Corp market quotes include the latest QGLY price and fundamental investing data, price charts and news. You can also get free,
The Quigley Corp Health Prices & Reviews - NexTag Compare Cheap Prices for The Quigley Corp Health at NexTag.com. Shop for Bargain Sporting Goods, Toys, Collectibles, Car Parts, Food, and the Good Things in Life.
Sponsored Links:

Software Forces QUIGLEY CORP THE Investors To Buy Low and Sell High The Position Cost Averaging Stock Investing Systems helps LONG-TERM investors in QUIGLEY CORP THE buy low and sell high every time guaranteed. Click Here To Learn More

We Give Precision Entry & Exit Points on QUIGLEY CORP THE. This software is specially designed to give precision entry and exit points on QUIGLEY CORP THE, or any other stock you choose.
Click Here to learn how to take control of your trading.

How To Know When QUIGLEY CORP THE Beats The Street. New Software Offers "One-Click" Stock Picks. The StockPickerRT will pick stocks for you every trading day based on earnings, volume & momentum. Maybe even QUIGLEY CORP THE, if they make the cut.
Click Here & Learn To
Pick Winners In An Uncertain Market



Related Searches: proton s long term strategy  spread trading  stock watch pro  tim lynch tercica  stock market option 

Research Home


Article Search


Advanced Search

StreetInsider Alerts

Latest Headlines

QUIGLEY CORP Financials (EDGAR Online Financials)

Quigley Announces Completion of Phase IIb Clinical Study of QR-333 For Diabetic Peripheral Neuropathy on November 25, 2008; Collection and Evaluation of Study Data to Begin Immediately Thereafter (PR Newswire)

QUIGLEY CORP Files SEC form 10-Q, Quarterly Report (EDGAR Online)

A Matrixx For Killing The Common Cold (at Investopedia)

QUIGLEY CORP Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statements an (EDGAR Online)

The Quigley Corporation Reports Third Quarter 2008 Results; Continues Investment in Pharmaceutical R&D Future (PR Newswire)

Quigley's New Kids-EEZE(R) Chest Relief OTC Expectorant Provides Alternative to Multi-Symptom Children's Cold Products That Could Potentially Lead to Overmedication; Patented New Soft Chew Tastes Great and Offers Parents of Kids, Ages Six a (PR Newswire)

Quigley Anti-Viral Compound QR448(a) Successfully Prevents Transmission of Infectious Bronchitis in Chickens (PR Newswire)

Quigley Announces Positive Follow Up Study of Poultry with Infectious Bronchitis: Results Demonstrate Longer Duration of Protection from Infectious Bronchitis and Reduction of Clinical Signs in Chickens (PR Newswire)

QUIGLEY CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits (EDGAR Online)

  Place Our Content On Your Site!  rss Powered By The Investing System Network
© 2006 Investing-News.Com, All Rights Reserved.